Attorney(s) appearing for the Case
Arthur Y. Tsien, Olsson, Frank and Weeda, P.C., Washington, DC, for Plaintiff.
Andrew E. Clark, U.S. Dept. of Justice, Office of Consumer Litigation, Washington, DC, Peter Blumberg, U.S. Attorney's
Office Civ. Div., Washington, DC, for Defendants.
United States District Court, District of Columbia.
HUVELLE, District Judge.
This is the latest installment in the longrunning battle to determine which will be the first company permitted to market a generic version of the drug gabapentin. Competing for this privilege—and, more importantly, for the statutory right to sell the drug for 180 days free from generic competition—are plaintiff TorPharm, Inc. ("TorPharm") and intervenor-defendant Purepac Pharmaceutical Co...
NEVER MISS A DECISION. START YOUR SUBSCRIPTION.
Uncompromising quality. Enduring impact.
Your support ensures a bright future for independent legal reporting.
As you are aware we have offered this as a free subscription over the past years and we have now made it a paid service.Look forward to your continued patronage.